Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
looking at the last 2 links to this 'analyst' target price, there is nothing positive in the numbers to justify the target price..
Be interesting to find out WHO this analyst is and his written justification..
PS: bitcoin might be a better trade cause someone said thats WORTH/going to $300,000... and if enough believe it, they could make it happen.. (now there is a Ponzi scheme) What was really funny were the couple of folks I listened to as they tried to justify their 'target prices' for bitcoin. When they were done embarrassing themselves, they should have just said right off the bat, its going to this $ value 'because I said its worth that' and left it at that.
well if de-listing is a concern, then this should help keep the share price up over the $ minimum needed..
Otherwise, $10 in a year for something needing to raise money, no product for at least a year and some change, and based on what?? A potential buy-out??
Actions like this is what gives the stock market a bad name... and TSLA to the moon, etc... We need to get back to a market where the companies fundamentals and realistic prospects are the basis for share prices...
disclaimer: own none after a fast trade during the run up, but interested. Was just wondering where its going to settle down at first... before I considered a new position.. and note: this is not saying TMDI can't get to $10, but sure would like to see the 'justification' this analyst used first..
5 'green' days out of the last 19 if one counts were the share price closed equal to the day before on 2 of the 5..
For the last 5 WAVES/cycles, its been consistently lower peaks and troughs.
Been looking for buy signal, but between the PM sector running out of gas in Aug and heading south, and AXU indicating that the ramp up in production isn't till Q1 (beyond the 'cleaning out' of the residue in the first mine they are working on), and with end of season tax loss selling coming up...
Not seeing a buy signal 'yet'.. and quite frankly, at this point, since I am out, I would like to see it take another run at $2.3 or less..
raise the potential return cause if this PM sector stays under pressure, AXU may rise, but not find a lot of folks paying attention for the really 'good gains ($7.5+ range) I was hoping it have a shot at..
Chart says:
1st of all, said it some time ago, worst nightmare with AXU is they finally get their permit and 'no one cares' cause gold and silver have fallen out of 'favor', prices 'flat/falling'. Thats already in progress, and the question is, can the 'enthusiasm' for the sector be restored?? Suspect its going to be tough cause a whole lot of folks were involved in driving it up to $1900 and where will the next round of participants come from.. Cause one has to expect, the 'pros' and promoters are likely already 'all in' at this point... and how many 'little people' can they entice to run it up again? Don't know, with time we will know..
2nd: I don't own shares having sold at $2.58/9, tried a small batch at $2.4 and got out again cause of the above and AXUs slower than expected progress on getting going, or as it looks now, not seriously getting going until Q1 in 2021, with results in Q2??
and chart is showing continued consolidation/oscillation $2.4=$2.5 range.. So looking like I don't need to be in a rush at the moment to reload for next summers ramp up to full production...
While its pulled back as expected from its PR post peak price, the last 3 days show it trying to hold the $17.3 level which is right where the Moving Average timeline I use is at.
BUT, the momentum indicators I use have turned negative so expecting it to breakdown some more from here.
Still looking to see if the GAP theory will apply here, ie, will the GAP that took place on the day of the PR be 'filled'?
disclaimer: own PUTs on it, ie, placed a bet to challenge myself whether or not what I think will happen, happens.. IF it breaks down below $17.20??
and last I checked, around 90,000 shares traded up till around 2 PM implying that whoever is holding shares, has either decided to 'sit tight' with them and at the same time, not too many interested in accumulating at the moment. Perfect setup for a decision to develop of, can it hold or does it drop... before the next PR takes place..
Wow. really quiet over here and I thought it had gotten 'quiet' before...
Ok, as a disclaimer:
have built up my position to what I want since I sold out before the r/split, last add was on the dip to near $10 yesterday...
see they are near or at the 75% enrollment point on their PH 3, some presentations coming up..
Hopefully this closes the DEC OE day under $15.. 10 days to go with the presentations taking place Dec 5-8th IF I remember the dates right..
Seen this 'show' far too many times over my time in the market..
Why I learned when these happen to 'take what its giving'.
and as far as 'scooping up shares', its not clear where this is going to bottom out at.
So don't be in a hurry trying to bottom fish until it confirms its hit rock bottom..
Or as I believe it was Burt Baruch who said
"made my money by not being the first to buy, nor the last to sell'...
yep, momentum can be a bitch when its lost...
Especially if those that were chasing were just there for the 'ride'... as long as it lasted..
Honeycomb777
good to see someone questioning things.. Keep it up..
disclaimer: just found this one in the last couple of weeks, really interested in the 'timeline'... for commencing the trial...
Can you share the direct link to this 'document' on the SEC.gov you are referring to?? especially 2nd one down on sec.gov - MD&A dated 11/16/20
Went to the SEC.gov site, searched TITAN MED, saw one dated 11/16, but not sure if this is the one you are referencing.
thanks in advance
disclaimer: own no shares after flipping some in less than a day of holding for nice gains since I am currently in a 'take what it gives' mode until this thing bases after this run up...
is this run coincidental to meeting a listing reqt??
Saw some chatter about needing to be above a $ for 10 days... to help stay 'listed'??
Is this run coincidental to this chatter??
Undervalued?? What is its 'current' valuation and basis??
.usually those who speak it have missed the big run like TMDI doubling the last 10 days and still way undervalued
Curious to know.
disclaimer: new to this one, some catching up to the rest of you to do...
and reason for entering is quite simply that I like the 'idea', would have been a lot happier if this hadn't jumped late last week the way it did..
I am out of AXU totally now...
reason: the PM sector 'bubble' is in trouble, the downtrend that started in early Aug has a grip on the miners, PM prices... yes they are making an attempt now and then to resurrect themselves, but they have failed a few times now since the slide commenced.
And at the moment, I do have a lot of miner charts showing that a 3 day 'pause' is underway... Reading that to imply, they are looking for direction..
and I got out of AXU altogether because of something I live by.. That a company has a fleeting moment in which to make a 'move'... And if AXU had only been fortunate to get their damn permit last spring when the PM sector took off seriously, I could easily see them at $7.5 plus on the news they were commencing mining. Now even if they commence mining, if the sector is under pressure, the miners sliding, will enough care to even push it over $4 on the news??
But at the same time, after digesting this latest news, I am looking for a potential 'play' on the ramp up... heck, a buy at $2.50 or less with a move to just $3.50 would be a nice gain...
Thats what they said some years ago when solar production took off in a big way...
While I am looking for an update, I am kind of hoping they hold off till after the Dec OE day or the news is just good enough to not push the share price over $15..
Picked up $6500+ some from selling covered call on 4000 shares...
Suspect due to the low share count, the market is giving a nice volatility premium on the shares.. For the last few months now, selling the covered calls has paid off very nicely..
just hope to keep the shares for another round in Jan... and note, started selling them at the $10 strike price back in Sept, then $12.50s, then $15s, now have some at the $17.50 level with the bulk of them at the $15 strike price.....
Why in the world is silver going to be trading at even $30/oz on a SUSTAINED basis unless supply gets tight in the face of 'demand'..
WHY? And I ask this seriously because I have followed gold/silver, traded positions for several years now (since around 2014). And while they have had a few serious runs since 2008, they don't/haven't held those gains. And it was the dip after 2011 that gave me an entry so that I could sell physical for gains this year...
And during this time, I have researched, debated with folks as to WHY they should do any.thing more than at a minimum, provide some degree of profits for everyone involved in the mining of, moving of to market and sellers of.
What else is justified beyond that for silver and gold are no longer 'tied' to anything other than supply and demand for the physical available.
Asking seriously, because till now, while many work hard to justify their 'calls' for this and that price, none of it works out that way until they can create a 'run' in the sector, as it happened this year...
and on that note, as long as the price of silver can stay above $17, I suspect we can see AXU once it starts mining looking for at least $5/sh... But who knows what happens if the sector falls out of favor..
disclaimer: don't own any at the moment, looking for a buy in point and should have grabbed some when it dipped below $2.35..
doing this with CRMD, which has a FDA decision day of 28 Feb...
been selling covered calls on 'non-core' shares.. But not selling them on the core shares cause of surprise news releases as they did this week has cost me approx $20,000 in covered calls NOT sold.. while I have waited..
But have approx 8000 shares 'at risk' today because of unexpected news (current share price 9 cents over the strike price)... likely buy the calls back before the close today and sell the Dec ones for more gains.. (see if they will give 50 cents/sh for the 8s...
market loves to prove us wrong as often as it can doesn't it (smile)...
Does today count?? $2.45/46 bid/ask at the moment...
Chart is hinting that $2.40 could be tested if something doesn't spark buying interest...
for the PM sector or AXU itself
disclaimer: don't own any now... posted why... see if it holds $2.40.. and every penny below that, makes a $5 target price look a lot better.
had a few more minutes to look into this one.. Just got into their clinical trials, 3 in 'progress', with the most advanced one being the PH 2... But just caught that this PH 2 is not scheduled to complete till the time period of 2022-2024.. then a PH 3 has to be run??
This one isn't worth a $5 spot let alone $20... wow, wonder who in the heck is buying shares at this price level, this far in advance...
disclaimer: what am I missing?? But do own some PUTS due to the perceived overvaluation..
the decision:
sold AXU at $2.58 last week... my goal with this one was to see if it could reach for $5... that would be about a 80% return on my latest buy.
But I have two others that are on the verge of applying for or getting an FDA decision on their drug developments.
CRMD has an FDA decision date on Feb 28th. ATNM is in the middle of a PH 3 that by some indications, there is a potential for them to ask for an early halt and move towards approval for reasons.
And IF these 2 do what I see them doing, both of them can be expected to run, with a minimum of a 200% return. And in the meantime, on ATNM, getting really nice prices selling their covered calls at strike prices up to $5 above the current price.
So given this, I may not buy AXU back now cause the 'grass MIGHT be' greener elsewhere IF an unexpected surprise does not occur.
Not sure whats going on, but seeing buying demand/pressure building.
Been flipping covered calls for gains, closed out the Nov 12.5 for gains, got some nice prices on the Dec 15s and even the Dec 17.5 ($1.32) with the share price at $12.5 range.
Still seeing the data/info I am aware of indicating their effort 'works', and again, its not a 'cure' in the sense of what most developmetns attempt to accomplish. But it 'appears' to help/assist, and IF this is an accurate assessment of whats been seen, it would appear to be a candidate for a NDA submission.
disclaimer: hold shares, selling covered calls and hoping like heck any move gives me time to close them out.. (ie, concerned due to the low share count of a move spiking the price beyond the strike prices before I can get out of the way)...
first of all, the evidence is showing IF we still have a rule of law left in America, many dems could be jail before the end of the year for trying to pull of major vote fraud...
as far as AXU goes, the primary reason I like it is, as long as the price of silver stays above say $17, they are going to be making money....
Whereas many existing miner share prices ran up as their profit margins increased, they will see their share prices slide IF the price of silver drops cause they are already producing at max levels.
AXU has the benefit of having 'nothing' to max...
check out THEGATEWAYPUNDIT.com for the REAL NEWS concerning the VOTE FRAUD that was attempted. Again, 'some' need to go to jail for doing this.. and I really hope they find the ones that ran this effort, not just the useful idiots at the deckplate level that actually committed it (like the poll workers violating state laws while 'counting' votes, et al)
oops: hit $2.45 this morn...
Moderna vaccine news hit the PMs this morn...
if I can reload at even $2.45, thats a 5% extra 'return' to the price point I sold out at..
IF I heard them right, whats taking place is the 'cleaning up' of whats left in the one mine, that will then be shut down. Will that be a net positive event for them or not is to be determined.
Then they will be ramping up production in the 1st qtr 2021 (sometime in the 1st qtr) and based on some of their other comments, they have some work to do in parallel that I suspect will slow down the commencement.
Therefore, I was disappointed in what I heard for the short term, not for the long term. But given the pressure the PM sector is under, given that AXUs chart is under a little pressure and has a downtrend in progress, and that I have a better short term option to make a little bit, I decided to sell out at $2.58/59 just as the Q&A was starting... and only heard wwhat I think was 2 questions being asked??
Decided to make a little over the next month in something else, and see if I can get back in a little bit cheaper..
and yeah, I know, its possible it takes off, but my patience with this one is running thin after an 18 month delay from when I thought they were going to get their permit
well, looks like its going to hinge on what they say at the CC today, cause the release last night didn't get the markets attention...
correct me if I am wrong, but they say they have 35 Million shares outstanding, just indicated they are going to sell ATM 5 Million more..
And today, 22 Million shares traded...
yesterday it was 75 Million...
In many circles, that is one heck of a lot of 'turnover' going on..
interesting..
wonder how many now own positions with a cost basis above $20/sh??
disclaimer: Day 2 post PH 2 data release..
help me understand this one here:
-this was just a phase 2 trial. Results appear good enough to get a PH 3 designed and run (at least 2 years to complete??)
-they just announced a 5 Million share at the market share sale. This far out, and with no earnings, no need to talk about the dilutive effect on 35 Mil shares outstanding, for I expect there will be more secondaries in the future..
-they just lost 74 cents/sh in the last quarter IF I read their earnings release correctly..
To me, this looks like a classic Wall Street pump and dump set up... designed to help the company raise money on relatively weak news with respect to future earnings/revenues cause its only a PH 2..
So what am I missing?? That justifies folks paying up to $24-26/sh for something not worth $5 for at least another full year??
disclaimer: said it yesterday that I bought Dec $5 Puts with the share price at $19.60... (was up 60%+ at the close last night on them, laughing this morn when I saw it opening up as it did, wondering what in the hell are folks doing as I explained to my son how MOMENTUM and NOISE can make people do foolish things)
well damn... just checked their website for the CC I thought was today, the 1wth, only to see its saying its tomorrow, the 13th instead at (8 AM PST) (11 AM EST)
Nov 13, 2020 11:00 am ET/8:00 am PT
Dial toll free from Canada or the US 1-800-319-4610
Dial from outside Canada or the US 1-604-638-5340
Ask to join the Alexco Conference Call
Live audio webcast services.choruscall.ca/links/alexco20201113.html
well isn't the real issue one of, why wouldn't the results be replicated??
Its a rather very straight forward trial, almost a 'go-no go' trial to a degree in that it either works or it doesn't..
and it appears easy enough to confirm whether or not it does.
Bottom line is, if the data in the trial arm is valid data, and the control arm fails to support the trial due to the current standard of care being what it is...
Not sure what your issue is with respect to them asking the FDA for early termination... Now I will agree, IF the data/effectiveness seen is questionable in that its not doing what they are looking for it to do, yeah, I would expect the FDA to say, redesign or continue the trial to completion..
But that does not seem to be the issue based on what they are indicating...
Morning...
another board alerted me to the 'news' of yesterday on this one. But this is only a PH 2, and while I have never shorted a stock, IF this thing jumps this morn in the premarket, I will be looking to buy PUTS on it.. (but the current option range isn't conducive to a good PUT trade unless they add some strike prices.. damn...)
and those with gains, as this was only a PH 2, you may seriously want to consider locking those gains in. Cause unless they can get fast tracked off this Ph 2 to approval, the share price is NOT likely to hold...
not with at least a 2 year PH 3 to run..
looking at a chart this morn in the pre market, up at $21 at the moment, but on very light volume... not a good time or price to be buying at. Mercy, seen this horror show too many times before..
disclaimer: just heard about this one this morn, a few minutes ago, enough time to read thru yesterdays news, see that its a PH 2 and having been around bio developments for around 20 years, will be looking to PUT this one. But added it to my 'watch list', going to investigate it closer, watch its PH3 development... see what its future holds.. Good luck.
Tomorrow, Nov 12th...
Will they finally say something, with silver over $24/oz to propel this thing back over $3 and rising??
Boy has it been a long hold on this one with the last 18 months being due to the damn delay in getting their water permit and then getting going..
any reason to reject the results of the PH 2 and or expect them to be any different in the PH 3?? Is 30% at 1 year, 20% at 2 years vs no survivors from the PH 2 at 2 years in the salvage arm?? Not to mention the shortened time to treatment thanks to the conditioning??
From my recall, the goal was to improve the results of not using it..
insert-text-here
In a Phase 2 clinical study in 58 patients with advanced AML or high-risk myelodysplastic syndrome (MDS) age 50 and older, Iomab-B produced complete remissions in 100% of patients and these patients experienced transplant engraftment at day 28. The overall survival rate of the 36 relapsed or refractory AML patients in the proof of concept study was 30% at one year and approximately 20% at two years. See Iomab-B study results here.
there is this article on results published back in Feb 2019.. I have to keep reminding myself that this is just something that is designed to make something else 'more achievable/effective'... ie, if you use it, does the 'standard of care' currently in use work 'better' than it does... Unless this trial interim readout shows the standard of care currently in use is just as 'good' or that the pre-conditioning adds no value... But the prior results appear to say, pre-conditioning makes the 'standard of care' better, more effective... but at the same time, even if approved, I don't see the share price doing a heck of a lot more than $20 ($220 Million market cap)
to sum it up? Does Iomabb make the standard of care better or not?? Based on whats been reported, sounds like it..
https://www.onclive.com/view/iomabb-shows-promise-as-novel-conditioning-for-hsct-in-aml
February 24, 2019
After taking another look at the 10Q, bottom of page 17, into page 18, my take is that the trial is going well (extension of prior 'results'), but that due to the 'control arm' failing to give them a meaningful comparison (ie, so many in the control FAIL to meet a standard of expectation, its useless for comparison sake) its FUTILE to continue the trial.
So as I read this again, and based on prior 'results' as described below, I will defer back to that comment not so long ago that its likely based on what they already know, and what they expect to see, that they are expecting to ask the FDA for an early termination and proceed to an NDA submission.. (marked some in italics, some in bold, but not sure what it will look like as 'preview' doesn't translate to final view)
Safety and feasibility data from the first 75 patients enrolled on the SIERRA trial, which represents 50% of the total of 150 patients to be enrolled in the trial, was presented in an oral presentation at the Transplantation & Cellular Therapy (“TCT”) Meetings of the American Society for Transplantation and Cellular Therapy (“ASTCT”) and Center for International Bone & Marrow Transplant Research (“CIBMTR”) in February 2020. It was reported that 100% of patients (31/31) on the study arm that received a therapeutic dose of Iomab-B received a BMT, with a median time to BMT of 30 days, and all patients achieved neutrophil and platelet engraftment in a median time of 20 days despite a high median blast count of 30%. On the control arm, only 18% of patients (7/38) achieved remission after salvage therapy, and then received a BMT with a median time to BMT of 67 days and median blast count of 26%. Of the 82% of patients failing to achieve a CR with conventional care (31/38), 20 patients were eligible to cross over to receive Iomab-B followed by transplant. These patients are considered as having failed the primary endpoint of the study. All crossover patients who received the therapeutic dose of Iomab-B (20/20) received a BMT, with a median time to BMT of 64 days and they achieved engraftment in a median time of 19 days despite high median blast count of 35% at time of crossover. It was also reported that 100-day non-relapse transplant-related mortality (100-day TRM) of the study or Iomab-B arm was only 6% (2/31) of patients that received a BMT compared to 29% of patients (2/7) who received a BMT after salvage therapy on the control arm. The universal engraftment rate and low 100-day TRM rate of the Iomab-B arm resulted in 29 patients potentially evaluable for the primary endpoint compared to 5 patients in the control arm, a nearly six times difference.
17
We have reached 75% enrollment in the SIERRA trial. We expect to present safety and feasibility data including rates of BMT engraftment, 100-day TRM and key safety metrics from 113 patients, representing 75% of the planned 150-patient enrollment, as we did on the first 25% and 50% of patients. In addition, rates of CR and rates of patients that did not achieve CR who then received Iomab-B, defined as failures for the primary endpoint, will be reported for patients randomized to the control arm.
The SIERRA trial is powered to show a two-times difference in the primary endpoint of dCR at 180 days at full enrollment of the study. The SIERRA trial design allowed for up to two ad hoc interim analyses of the primary endpoint exercisable at our discretion and triggered by an enrollment range of 70 to 110 patients. We exercised a single ad hoc interim analysis in the second quarter of 2020 based on the data reported from SIERRA thus far that is consistent with prior findings with Iomab-B and have updated and shared the updated SIERRA trial protocol and statistical analysis plan with the FDA to reflect the single ad hoc interim analysis. With a single ad hoc interim analysis exercised, the final analysis on full enrollment of 150 patients would be conducted with a p-value of 0.046 defining success of the trial. The interim analysis is expected to be completed in the fourth quarter of 2020 and could result in a recommendation for early termination of the trial for futility of one of the arms, or a continuation of the trial. The company intends to consult with the FDA should the recommendation be to terminate the study due to futility of the control arm.
noticed the same 'change' in the outlook from early termination because of potentially good results to what you are now referring.
and the inclusion of 'because of futility'..
Because of the PH 2 results, because I was expecting this trial to mimic the PH2 just on a larger scale, I was expecting 'good' results vs 'bad results'...
Didn't get into it beyond the initial read, but thought of an email to IR to ask about the change in the language. Just hadn't gotten around to to doing it.
disclaimer: own shares, some under Nov 12.5 covered calls, some under Dec 15s. And with this drop pondering whether or not to close the calls out for the gains I could take (due to the share price slide) and resell another batch IF the price comes up, or just let them ride as is..
not surprised to hear this. The PM sector miners have been in a slide since early Aug..
Can see where now and then there is an effort to buy the dips/lift the sector, but for many of the 70 miner tickers I follow, the trend has been for lower...
kind of thinking the sectors 'momentum' has taken a temporary hiatus..
hold shares from around $2.75-2.8, that I bought in mid Aug after selling them higher (and this is after flipping shares a few times since it left the $/sh price range some time ago)
So have done well with this one for some time now... And thought of selling these as the chart started to hint at a slide developing, but was afraid they would make an announcement and spike the price up.
So been watching and figured $2.5 would be a good buy range... It might dip some more, but added today at $2.55..
Figuring $3.5 would be a nice gain, and anything higher, even better.
Would like to get $5, and suspect they will if the price of silver holds over $20, all going to depend on their 'profit margin' and rate of ramping up the tonnage processed..
Good luck...
Have an 'awareness' going on the Investor Village Precious Metal board..
And there are a couple of others that appear to own 'some' shares..
and quite frankly, my approach is to put it out there a few times, why and
let folks decide for themselves.
Biggest concern is, the PM sector has been in a slide since early August.
When AXU announces commencement, will anyone 'care' if the sector is
under selling pressure??
Cause sure don't seem to see it being 'talked' about... (ie, not one of the ones being promoted by they hypesters)..
Fully agree with you...
But again, I don't like to buy and hold based on PH 2 trials unless the data is very compelling, and with very good odds of replication in the PH 3.
IE, I don't mind paying more if thats what happens.
But I am not against trading a PH 2 data dump IF even there, the odds favor a positive result... So yeah, based on what they just said, I am a thinking the Rhett PH 2 is going to be a tradeable event..
The only question after data releases like these is, will the share price wander lower as the run to the next event commences..
and agree, IF I could get some sub $5, that would be nice for me.. If I pay higher, it will be what it is..
Oct options expiration..
lost 500 shares to the Oct $10 covered calls, but as I had gains on both the shares and the calls, ok with it happening.
So when the share price faded this morn to sub $11.9, added a 1000 more shares and sold the Dec $15s calls for $2.25/sh. Gains anticipated:
min: $2247 on the calls
max: $2247 on the calls + $3.12/sh for a total gain of $5367 for 2 months of holding... be a 45% gain...
have something similar going on with the Nov $12.5s, but not as good for a little over a one month holding.. and unfortunately, those calls are looking in jeopardy far too early..
disclaimer: only doing this because of the aspect that IF ATNM has to complete their PH 3? They are looking at Dec 2021 to do so... and yes, aware that they might have a PH 3 interim data PR in late Dec/Jan and a potential trial halt...